Wednesday, 14 Nov 2018

You are here

The RheumNow Week in Review – EULAR18 Epilogue (6.22.18)

Dr. Jack Cush reviews EULAR 2018 and the past week's news and reports from RheumNow.com, including DMARDs in OA, the price of Penicillamine, Infections when ANCA+, CV outcomes in gout, NSAIDs in Pregnancy and Seropostive vs. Seronegative Outcomes.

  1. Metanalysis of 11 RCTs show that DMARDs and biologics are no better than Placebo in treating symptomatic Osteoarthritis https://t.co/OGwvaEglhZ
  2. Pts w/ ANCA+ assoc vasculitis may be at risk for serious infection, esp during induction. Study of 248 pts shows SIE in 1/3 of pts - risk factors for SIE include: Age, smoking, Cr ≥5.7, CD4+ T cell< 281, IV-CYC https://t.co/WYuaaCi8Fn 
  3. Among 113 JIA patients, screening with fecal calprotectin levels found 7/113 with two consecutive elevations of FC. On colonscopy, all patients had IBD. https://t.co/tNoNOuh12Q
  4. Using medicare claims data, Singh & Cleveland show that elderly >65 yrs gout pts have a risk of MI = 4.1 per 1000 PYs and is 2 fold higher than those without gout. https://t.co/jozY7tc40r
  5. Unbelievable!t Cuprimine (Penicillamine) is one of the most expensive drugs on the market. Annual cost $31,426 ($261.89/tablet) & for Wilson’s Disease. >50yrs old, side effect ridden & objectionably expensive! Shame on Valeant. Congress help w/ drug prices https://t.co/7Tb4fDg0kH
  6. NSAID Use Around Conception Increases Miscarriage Risk  
  7. The Stress - Autoimmune Disease Connection 
  8. Seronegative and Seropositive Rheumatoids Respond Equally Well

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

MMWR: Death by Firearms

The CDC's Morbidity and Mortality Weekly Report (MMWR) reports that during 2015–2016 there was a total of 27,394 firearm homicides and 44,955 firearm suicides among US residents, with 12% and 5% of events occuring in children 10–19 years.

RheumNow Weekly Podcast – 3 Wiseguy Rheumatologists (11.9.18)

Dr Jack Cush reviews the News and Journal reports from the past week on RheumNow.com.  Be sure to check out our upcoming meeting in March 2019 - RheumNow Live.

E/M Guidelines: Right Road, Wrong Direction

Last July, the Centers for Medicare & Medicaid Services (CMS) proposed new E/M guidelines for office visits with physicians. It issued the final guidelines on November 1, with a few tweaks. Implementation was delayed until 2021 (from 2019), possibly due to overwhelming opposition from physicians.

RheumNow Week in Review – The Heart Attack Report (11.2.18)

Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

'These Results Are Astonishing': What We Heard at ACR 2018

"If radiation was a drug that could improve survival in the metastatic setting like that it would be millions and millions of dollars." -- James B. Yu, of Yale Cancer Center, discussing aggressive use of stereotactic body radiation therapy in oligometastatic cancer.

*******************************************************